<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00107796</url>
  </required_header>
  <id_info>
    <org_study_id>C1538/3027/NA/MN-Narcolepsy</org_study_id>
    <nct_id>NCT00107796</nct_id>
  </id_info>
  <brief_title>Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy</brief_title>
  <official_title>A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cephalon</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Teva Branded Pharmaceutical Products R&amp;D, Inc.</source>
  <brief_summary>
    <textblock>
      Primary Objectives: The primary objectives of the study are to determine the effectiveness of&#xD;
      PROVIGIL treatment, compared to placebo treatment, in children and adolescents with excessive&#xD;
      sleepiness (ES) associated with narcolepsy, as assessed by:&#xD;
&#xD;
        -  mean sleep latency from the Multiple Sleep Latency Test (MSLT) (average of 4 naps&#xD;
           performed at 0900, 1100, 1300, and 1500) at the last post-baseline observation (week 6&#xD;
           or early termination)&#xD;
&#xD;
        -  the Clinical Global Impression of Change (CGI-C) ratings for ES, at the last&#xD;
           post-baseline observation (week 6 or early termination).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date>September 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean sleep latency from the Multiple Sleep Latency Test (MSLT) (average of 4 naps performed at 0900, 1100, 1300, and 1500) at the last post baseline observation (week 6 or early termination)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>The Clinical Global Impression of Change (CGI-C) ratings for ES, at the last post baseline observation (week 6 or early termination)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression of Change (CGI-C) ratings for ES at weeks 3 and 6</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total score from the Pediatric Daytime Sleepiness Scale (PDSS) at weeks 3 and 6, and last postbaseline observation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean sleep latency from the MSLT (average of 4 naps performed at 0900, 1100, 1300, and 1500) at week 6</measure>
  </secondary_outcome>
  <enrollment>140</enrollment>
  <condition>Narcolepsy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Modafinil</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Diagnosis and Main Criteria for Inclusion (Patients are included in the study if all of the&#xD;
        following criteria are met):&#xD;
&#xD;
          -  Written informed consent/assent is obtained&#xD;
&#xD;
          -  A boy or girl aged 6 through 16 years, inclusive&#xD;
&#xD;
          -  Meet the minimal criteria established by the International Classification of Sleep&#xD;
             Disorders (ICSD) manual of the American Academy of Sleep Medicine (AASM) for&#xD;
             narcolepsy (or presumed narcolepsy) as assessed by all of the following: *clinical&#xD;
             history;&#xD;
&#xD;
               -  NPSG (nocturnal polysomnogram) (as evaluated by the investigator) to rule out&#xD;
                  other sleep disorders (ie, obstructive sleep apnea/hypopnea syndrome [OSAHS] or&#xD;
                  periodic limb movement with sleep [PLMs]);&#xD;
&#xD;
               -  narcolepsy (or presumed narcolepsy) as identified by at least 1 of the following:&#xD;
                  MSLT (as evaluated by the investigator) (mean sleep latency [from 4 naps] &lt;10&#xD;
                  minutes); 2 sleep onset REM periods (SOREMP); cataplexy; sleep paralysis;&#xD;
                  hypnogogic hallucinations -OR- *have a previous diagnosis of narcolepsy on the&#xD;
                  basis of NPSG and/or MSLT at any time before the screening visit&#xD;
&#xD;
          -  Have ES (MSLT &lt;10 minutes and/or CGI S ≥4) that is not a direct result of inadequate&#xD;
             sleep hygiene or other medical disorder&#xD;
&#xD;
          -  Are in good health as determined by a medical and psychiatric history, physical&#xD;
             examination, ECG, and clinical laboratory tests&#xD;
&#xD;
          -  Have blood pressure values greater than those for the 5th percentile and less than the&#xD;
             95th percentile for age on the National High Blood Pressure Education Program&#xD;
             guidelines for blood pressure levels for boys and girls ages 6 through 16 years&#xD;
&#xD;
          -  Girls who are post menarche or sexually active must have a negative urine pregnancy&#xD;
             test prior to the baseline visit, must be using a medically acceptable method of birth&#xD;
             control, and must agree to continue use of this method for the duration of the study&#xD;
             (and for 30 days after participation in the study). Acceptable methods of birth&#xD;
             control include: barrier method with spermicide; steroidal contraceptive (eg, oral,&#xD;
             transdermal, implanted, or injected) in conjunction with a barrier method;&#xD;
             intrauterine device (IUD); or abstinence.&#xD;
&#xD;
          -  Be able to swallow a placebo tablet the same size and shape as the study drug tablet&#xD;
&#xD;
          -  Negative UDS (urine drug screen) for any illicit drug, alcohol (ethanol), stimulants,&#xD;
             or modafinil at screening; if positive for stimulants or modafinil (prescribed for ES)&#xD;
             at the screening visit, UDS to be repeated after a washout period and before the&#xD;
             baseline visit&#xD;
&#xD;
          -  Have a parent or legal guardian who is willing to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Main Criteria for Exclusion (Patients are excluded from participating in this study if 1 or&#xD;
        more of the following criteria are met):&#xD;
&#xD;
          -  Have any other disorder(s) that could be considered the primary cause of ES (eg, self&#xD;
             induced sleep deprivation)&#xD;
&#xD;
          -  Have a past or present seizure disorder (except history of a single febrile seizure),&#xD;
             a history of psychosis, or of clinically significant head trauma (eg, brain damage) or&#xD;
             past neurosurgery&#xD;
&#xD;
          -  Have a history of suicide attempt, or are at suicidal risk&#xD;
&#xD;
          -  Have an average of 5 or more apneic/hypopneic episodes per hour of nocturnal sleep as&#xD;
             assessed by NPSG at the baseline visit&#xD;
&#xD;
          -  A clinically significant drug sensitivity to stimulants such as amphetamine,&#xD;
             dextroamphetamine, methylphenidate, or pemoline; and/or modafinil or any of its&#xD;
             components&#xD;
&#xD;
          -  Use of any prescription (eg, clonidine, guanfacine) or nonprescription (over the&#xD;
             counter [OTC]) medications, including dietary supplements with psychoactive properties&#xD;
             (eg, any OTC medications or supplements containing ephedrine [ie, ma huang or&#xD;
             ephedra], pseudoephedrine, caffeine, or phenylpropanolamine) or sedating properties&#xD;
             (ie, antihistamines or sedative hypnotics) within 1 week of the baseline visit (Note:&#xD;
             Medications for the treatment of cataplexy will be permitted if the patient has been&#xD;
             on a stable dose for at least 1 month.)&#xD;
&#xD;
          -  Use of any MAO (monoamine oxidase) inhibitors or SSRIs (Selective Serotonin Reuptake&#xD;
             Inhibitors) within 2 weeks of the baseline visit (unless used for cataplexy)&#xD;
&#xD;
          -  Received any investigational drug (except modafinil) within 4 weeks of the baseline&#xD;
             visit&#xD;
&#xD;
          -  Any disorder that could interfere with drug absorption, distribution, metabolism, or&#xD;
             excretion (including previous gastrointestinal surgery)&#xD;
&#xD;
          -  Active, clinically significant gastrointestinal, cardiovascular, hepatic, renal,&#xD;
             hematologic, neoplastic, endocrine, neurologic, immunodeficiency, pulmonary, or other&#xD;
             major clinically significant disorder/disease&#xD;
&#xD;
          -  Any clinically significant deviation from the normal range(s) in the physical&#xD;
             examination or ECG findings, or clinical laboratory test results (ie, serum chemistry,&#xD;
             hematology, and urinalysis) at the screening or baseline visit&#xD;
&#xD;
          -  ANC (absolute neutrophil count) below the lower limit of normal at the screening visit&#xD;
             (Note: If the ANC is below the lower limit of normal at the baseline visit, the&#xD;
             medical monitor will be consulted for continued eligibility in the study.)&#xD;
&#xD;
          -  Seated pulse outside the range of 60 through 115 bpm after resting for 5 minutes&#xD;
&#xD;
          -  A history of alcohol, narcotic, or any other substance abuse or dependence as defined&#xD;
             by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th&#xD;
             Edition (DSM IV) criteria&#xD;
&#xD;
          -  A total daily intake of more than 250 mg of caffeine per day (eg, approximately five&#xD;
             12 ounce caffeinated sodas, 2.5 cups of coffee or tea, or about 12.5 ounces of&#xD;
             chocolate per day) within 1 week of the baseline visit&#xD;
&#xD;
          -  Pregnant or lactating/nursing girl; any girl who becomes pregnant during the study&#xD;
             will be withdrawn&#xD;
&#xD;
          -  A clinically significant illness within 4 weeks of the baseline visit; or is&#xD;
             symptomatic for any clinically significant illness at the screening or baseline visit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Robert Doekel, Jr., M.D.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chris M. Makris, M.D.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barbara Harris, Ph.D.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derek Loewy, Ph.D.</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stuart Quan, M.D.</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joseph McCarty, M.D.</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John L. Carroll, M.D.</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samuel Boellner, M.D.</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Julie Thompson-Dobkin, D.O.</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mark Buchfuhrer, M.D.</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yury Furman, M.D.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stuart Menn, M.D.</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richard Shubin, M.D.</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lawrence Sher, M.D.</name>
      <address>
        <city>Rolling Hills Estates</city>
        <state>California</state>
        <zip>90274</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milton K. Erman, M.D.</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stephen Brooks, M.D.</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paul Haberman, M.D.</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jed Black, M.D.</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amerigo Padilla, M.D.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin A. Cohn, M.D.</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>D. Alan Lankford, Ph.D.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gary Montgomery, M.D.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jerry Silverboard, M.D.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charles Wells, Jr., M.D.</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stephen H. Sheldon, D.O., FAAP</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael Kohrman, M.D.</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anna Ivanenko, M.D., Ph.D.</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Lahmeyer, M.D.</name>
      <address>
        <city>Northfield</city>
        <state>Illinois</state>
        <zip>60093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook, M.D.</name>
      <address>
        <city>Danville</city>
        <state>Indiana</state>
        <zip>46122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Leeds, D.O.</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karen Waters, M.D.</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Margaret Ann Springer, M.D.</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helene A. Emsellem, M.D.</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marc Raphaelson, M.D.</name>
      <address>
        <city>Frederick</city>
        <state>Maryland</state>
        <zip>21702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daniela Minecan, M.D.</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>George Zureikat, M.D.</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Harsh, Ph.D., DABSM</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pradeep Sahota, M.D.</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Torch, M.D., MS</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kathleen Ryan, M.D.</name>
      <address>
        <city>Mount Laurel</city>
        <state>New Jersey</state>
        <zip>08054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sushmita Mikkilineni, M.D.</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monroe Karetzky, M.D.</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lee Brooks, M.D.</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marc Seelagy, M.D.</name>
      <address>
        <city>Trenton</city>
        <state>New Jersey</state>
        <zip>08629</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gary Zammit, M.D.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Lee, M.D.</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bruce Corser, M.D.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Raouf Amin, MD</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin Scharf, Ph.D.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carol Rosen, M.D.</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Markus H. Schmidt, M.D., Ph.D.</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael Neeb, Ph.D.</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William C. Orr, Ph.D.</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jorg Pahl, M.D.</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dainis Irbe, M.D.</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Pistone, M.D.</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jeffery Gould, M.D.</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guillermo Borrero, M.D.</name>
      <address>
        <city>Clairton</city>
        <state>Pennsylvania</state>
        <zip>15025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lee Brooks, M.D.</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Judith Owens, M.D., MPH</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richard Bogan, M.D., FCCP</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Julie Jacques, D.O.</name>
      <address>
        <city>Morristown</city>
        <state>Tennessee</state>
        <zip>37814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hudson, M.D.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Sperry, M.D.</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Todd J. Swick, M.D.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jerry J. Tomasovic, M.D.</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James M. Ferguson, M.D.</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ralph A. Pascualy, M.D.</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adam Moscovitch, M.D.</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2X2A8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leonid Kayumov, M.D.</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1S1T7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mortimer Mamelak, M.D.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2J2K9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colin Shapiro, Ph.D.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allen Denys, M.D.</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N9A1C9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2006</verification_date>
  <study_first_submitted>April 8, 2005</study_first_submitted>
  <study_first_submitted_qc>April 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2005</study_first_posted>
  <last_update_submitted>August 22, 2012</last_update_submitted>
  <last_update_submitted_qc>August 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2012</last_update_posted>
  <keyword>Pediatric Narcolepsy</keyword>
  <keyword>Excessive sleepiness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Narcolepsy</mesh_term>
    <mesh_term>Sleepiness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Modafinil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

